niclosamide has been researched along with Atheroma in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, T | 1 |
| Minami, M | 1 |
| Yoshida, K | 1 |
| Nagata, M | 1 |
| Yamamoto, Y | 1 |
| Takayama, N | 1 |
| Suzuki, K | 1 |
| Miyata, T | 1 |
| Okawa, M | 1 |
| Miyamoto, S | 1 |
1 other study available for niclosamide and Atheroma
| Article | Year |
|---|---|
Niclosamide downregulates LOX-1 expression in mouse vascular smooth muscle cells and changes the composition of atherosclerotic plaques in ApoE
Topics: Animals; Apolipoproteins E; Cells, Cultured; Down-Regulation; Mice; Mice, Inbred C57BL; Mice, Knocko | 2022 |